We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
-11.87%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+336.66%
AUM
$221B
AUM Growth
-$31.8B
Cap. Flow
+$2.77B
Cap. Flow %
1.26%
Top 10 Hldgs %
15.08%
Holding
8,767
New
731
Increased
3,710
Reduced
3,260
Closed
648

Sector Composition

Rank Sector Weight
1 Technology 8.03%
2 Financials 6.64%
3 Healthcare 6.26%
4 Consumer Discretionary 5.11%
5 Industrials 4.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ADMS
6351
DELISTED
Adamas Pharmaceuticals
ADMS
$35K ﹤0.01%
4,194
+729
+21% +$9.48K
PES
6352
DELISTED
Pioneer Energy Services Corp.
PES
$35K ﹤0.01%
27,864
+2,616
+10% +$6.51K
BRS
6353
DELISTED
Bristow Group, Inc.
BRS
$35K ﹤0.01%
14,469
+3,937
+37% +$29.8K
EDBI
6354
DELISTED
Legg Mason ETF Investment Trust Legg Mason Emerging Markets Diversified Core ETF
EDBI
$35K ﹤0.01%
1,315
SVA
6355
DELISTED
Sinovac Biotech, Ltd
SVA
$35K ﹤0.01%
5,026
GCVRZ
6356
DELISTED
Sanofi Contingent Value Rights
GCVRZ
$35K ﹤0.01%
73,031
+4,659
+7% +$2.31K
AGQ icon
6357
ProShares Ultra Silver
AGQ
$1.2B
$34K ﹤0.01%
1,280
-647
-34% -$15.3K
BFC icon
6358
Bank First Corp
BFC
$1.73B
$34K ﹤0.01%
+720
New +$35.3K
DSGX icon
6359
Descartes Systems
DSGX
$6.63B
$34K ﹤0.01%
1,281
-6,475
-83% -$189K
DTF
6360
DTF Tax-Free Income 2028 Term Fund
DTF
$81.3M
$34K ﹤0.01%
2,765
-1,325
-32% -$16.6K
DWSN icon
6361
Dawson Geophysical
DWSN
$148M
$34K ﹤0.01%
10,026
+4,190
+72% +$19.9K
IFRA icon
6362
iShares US Infrastructure ETF
IFRA
$4.61B
$34K ﹤0.01%
+1,489
New +$37.5K
IPOS icon
6363
Renaissance International IPO ETF
IPOS
$11.7M
$34K ﹤0.01%
1,819
-220
-11% -$4.28K
MEXX icon
6364
Direxion Daily MSCI Mexico Bull 3X ETF
MEXX
$19.9M
$34K ﹤0.01%
1,458
-110
-7% -$3.17K
MRNA icon
6365
Moderna
MRNA
$22.8B
$34K ﹤0.01%
+2,200
New +$36.2K
ORLY icon
6366
PUT
O'Reilly Automotive
ORLY
$74.9B
$34K ﹤0.01%
+1,500
New +$34.1K
SPG icon
6367
PUT
Simon Property Group
SPG
$73.3B
$34K ﹤0.01%
200
STRO icon
6368
Sutro Biopharma
STRO
$425M
$34K ﹤0.01%
376
+251
+201% +$30.3K
TGI
6369
DELISTED
Triumph Group
TGI
$34K ﹤0.01%
2,962
+2,467
+498% +$42.9K
TPOR icon
6370
Direxion Daily Transportation Bull 3X ETF
TPOR
$19.4M
$34K ﹤0.01%
1,788
-304
-15% -$8.49K
VRCA icon
6371
Verrica Pharmaceuticals
VRCA
$92.9M
$34K ﹤0.01%
416
+78
+23% +$9.47K
VRDN icon
6372
Viridian Therapeutics
VRDN
$2.3B
$34K ﹤0.01%
743
+31
+4% +$1.79K
VSHY icon
6373
Virtus Newfleet Short Duration High Yield Bond ETF
VSHY
$31.1M
$34K ﹤0.01%
1,459
+16
+1% +$383
XSHQ icon
6374
Invesco S&P SmallCap Quality ETF
XSHQ
$326M
$34K ﹤0.01%
+1,375
New +$37.9K
SCX
6375
DELISTED
The L.S. Starrett Company
SCX
$34K ﹤0.01%
6,477
-423
-6% -$2.34K

Similar funds

UBS Group's Q4 2018 Portfolio in Review

As of Q4 2018, UBS Group held 8,767 positions worth $221B, down 13% from $252B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

UBS Group's Q4 2018 filing shows 731 new, 3,710 increased, 3,260 reduced and 648 closed positions. Its largest new stake was Linde: 4,971,408 shares worth $776M. The largest sale was Energy Transfer Partners, L.P., an estimated $1.06B.

By sector, the portfolio is most concentrated in Technology at 8% of assets, down from 9.3% a quarter earlier, followed by Financials and Healthcare.

  • UBS Group's largest Q4 2018 buy was Linde: 4,971,408 shares worth $776M.
  • UBS Group added most to State Street SPDR S&P 500 ETF Trust in Q4 2018, an estimated $1.82B increase.
  • UBS Group's biggest Q4 2018 reduction was Colgate-Palmolive, cutting an estimated $665M.
  • UBS Group fully exited Energy Transfer Partners, L.P. in Q4 2018, selling an estimated $1.06B.
  • UBS Group's ten largest holdings make up 15% of its $221B portfolio in Q4 2018.
  • UBS Group opened 731 new positions and closed 648 in Q4 2018.
  • UBS Group's portfolio value fell 13% quarter-over-quarter to $221B.

Based on UBS Group's 13F filing for Q4 2018, filed 14 Feb 2019.